Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

88.16 -1.04 (-1.17%)
Streaming Delayed Price Updated: 9:49 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
Via Benzinga
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
From Edwards Lifesciences Corporation
Via Business Wire
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
Via Benzinga
The Latest Analyst Ratings For Edwards Lifesciences
Via Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
Via Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
Edwards Lifesciences Earnings Preview
Via Benzinga
Expert Ratings For Edwards Lifesciences
Via Benzinga
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Via Benzinga
FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document. 
Via Benzinga
Exposures Product Safety
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday. 
Via Benzinga
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
The company narrowly topped sales expectations and adjusted profit came in line. 
Via Investor's Business Daily
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Assessing Edwards Lifesciences: Insights From 14 Financial Analysts
Via Benzinga
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in... 
Via Benzinga
Topics Economy
Exposures Interest Rates
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
From Edwards Lifesciences Corporation
Via Business Wire
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Exposures Interest Rates
What Happened With Edwards Lifesciences Stock?
Edwards Lifesciences Corporation (NYSE: EW) shares traded higher on Wednesday. The stock surged despite any company-specific news. 
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.